Mastercard: COVID-19 Therapeutics Accelerator Awards $20 Million in Initial Grants
- Mastercard is a global technology company in the payments industry to connect and power an inclusive, digital economy that benefits everyone
- The Therapeutics Accelerator also is an initiative launched by the Bill & Melinda Gates Foundation
- The partners in the COVID-19 Therapeutics Accelerator announced grants of $20 million to three institutions the University of Washington
- These grants mark also the first investments to come from the COVID-19 Therapeutics Accelerator
- These initial investments through the COVID-19 Therapeutics Accelerator also will bring rigor to the study of these potential solutions
- The trials aim to determine whether the drugs are effective as pre- and post-exposure preventive therapy for COVID-19